IDT Biologika has established a new organization to serve the animal health needs of veterinarians, farmers and government agencies in the Americas. IDT Animal Health Americas will leverage the company’s global expertise and technology to offer a range autogenous, wildlife and commercial vaccines and diagnostic solutions for use in animals.

“Following IDT’s acquisitions in North America in 2015, and the recent acquisition of Ridgeway Biologicals in the UK, the new organization further strengthens IDT’s presence around the globe and unites all quality animal health development, production, approval and distribution activities for the Americas under one umbrella,” said Andreas Kastenbauer, head of IDT’s global animal health division. “By organizing our Animal Health business in the U.S. and Canada, arguably two of the most important markets in the world, we are rapidly advancing toward our goal of becoming the leading autogenous and commercial vaccine manufacturer in the Americas.”

José Ochoa, who joined IDT from Emergent BioSolutions in 2015, has been appointed head of the new regional business unit for the Americas, responsible for overall growth and operations. He takes on this new role within Animal Health while maintaining his position as chief business officer with IDT Biologika Corporation in Rockville, MD.

“IDT brings to the Americas deep and broad disease fighting expertise in a wide range of animal health conditions that impact livestock, poultry, and wildlife, including salmonella, edema, influenza, rabies and more,” said Mr. Ochoa. “We are currently building a sales network for solutions in swine diseases and our pipeline products. The company will continue to invest in the people and infrastructure needed to realize our full potential and to support future expansion into Latin America.”